 | • レポートコード：MRC2Q12-16805 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、鼻除菌薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 鼻除菌薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 鼻除菌薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 鼻除菌薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの鼻除菌薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の鼻除菌薬の売上および2028年までの予測に焦点を当てています。 鼻除菌薬のグローバル主要企業には、Global Life Technologies、PDI Healthcare、3M、Clorox Healthcare、Medline、GSK、Teva、Glenmark Pharmsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 鼻除菌薬市場は、タイプとアプリケーションによって区分されます。世界の鼻除菌薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 鼻用ムピロシン、鼻用ポビドンヨード、その他 【アプリケーション別セグメント】 病院、薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 鼻除菌薬製品概要 - タイプ別市場（鼻用ムピロシン、鼻用ポビドンヨード、その他） - アプリケーション別市場（病院、薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の鼻除菌薬販売量予測2017-2028 - 世界の鼻除菌薬売上予測2017-2028 - 鼻除菌薬の地域別販売量 - 鼻除菌薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別鼻除菌薬販売量 - 主要メーカー別鼻除菌薬売上 - 主要メーカー別鼻除菌薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（鼻用ムピロシン、鼻用ポビドンヨード、その他） - 鼻除菌薬のタイプ別販売量 - 鼻除菌薬のタイプ別売上 - 鼻除菌薬のタイプ別価格 ・アプリケーション別市場規模（病院、薬局、その他） - 鼻除菌薬のアプリケーション別販売量 - 鼻除菌薬のアプリケーション別売上 - 鼻除菌薬のアプリケーション別価格 ・北米市場 - 北米の鼻除菌薬市場規模（タイプ別、アプリケーション別） - 主要国別の鼻除菌薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの鼻除菌薬市場規模（タイプ別、アプリケーション別） - 主要国別の鼻除菌薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の鼻除菌薬市場規模（タイプ別、アプリケーション別） - 主要国別の鼻除菌薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の鼻除菌薬市場規模（タイプ別、アプリケーション別） - 主要国別の鼻除菌薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの鼻除菌薬市場規模（タイプ別、アプリケーション別） - 主要国別の鼻除菌薬市場規模（トルコ、サウジアラビア） ・企業情報 Global Life Technologies、PDI Healthcare、3M、Clorox Healthcare、Medline、GSK、Teva、Glenmark Pharms ・産業チェーン及び販売チャネル分析 - 鼻除菌薬の産業チェーン分析 - 鼻除菌薬の原材料 - 鼻除菌薬の生産プロセス - 鼻除菌薬の販売及びマーケティング - 鼻除菌薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 鼻除菌薬の産業動向 - 鼻除菌薬のマーケットドライバー - 鼻除菌薬の課題 - 鼻除菌薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Nasal Decolonization Drug Market
The global Nasal Decolonization Drug market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Nasal Mupirocin accounting for % of the Nasal Decolonization Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Nasal Decolonization Drug market size is valued at US$ million in 2021, while the North America and Europe Nasal Decolonization Drug are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nasal Decolonization Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nasal Decolonization Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nasal Decolonization Drug market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nasal Decolonization Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nasal Decolonization Drug market.
Global Nasal Decolonization Drug Scope and Market Size
Nasal Decolonization Drug market is segmented by players, region (country), by Type and by Channel. Players, stakeholders, and other participants in the global Nasal Decolonization Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Channel for the period 2017-2028.
Segment by Type
Nasal Mupirocin
Nasal Povidone Iodine
Others
Segment by Channel
Hospital
Retail Pharmacy
Others
By Company
Global Life Technologies
PDI Healthcare
3M
Clorox Healthcare
Medline
GSK
Teva
Glenmark Pharms
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nasal Decolonization Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Nasal Mupirocin
1.2.3 Nasal Povidone Iodine
1.2.4 Others
1.3 Market by Channel
1.3.1 Global Nasal Decolonization Drug Market Size Growth Rate by Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nasal Decolonization Drug Market Perspective (2017-2028)
2.2 Nasal Decolonization Drug Growth Trends by Region
2.2.1 Nasal Decolonization Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nasal Decolonization Drug Historic Market Size by Region (2017-2022)
2.2.3 Nasal Decolonization Drug Forecasted Market Size by Region (2023-2028)
2.3 Nasal Decolonization Drug Market Dynamics
2.3.1 Nasal Decolonization Drug Industry Trends
2.3.2 Nasal Decolonization Drug Market Drivers
2.3.3 Nasal Decolonization Drug Market Challenges
2.3.4 Nasal Decolonization Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nasal Decolonization Drug Players by Revenue
3.1.1 Global Top Nasal Decolonization Drug Players by Revenue (2017-2022)
3.1.2 Global Nasal Decolonization Drug Revenue Market Share by Players (2017-2022)
3.2 Global Nasal Decolonization Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nasal Decolonization Drug Revenue
3.4 Global Nasal Decolonization Drug Market Concentration Ratio
3.4.1 Global Nasal Decolonization Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nasal Decolonization Drug Revenue in 2021
3.5 Nasal Decolonization Drug Key Players Head office and Area Served
3.6 Key Players Nasal Decolonization Drug Product Solution and Service
3.7 Date of Enter into Nasal Decolonization Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nasal Decolonization Drug Breakdown Data by Type
4.1 Global Nasal Decolonization Drug Historic Market Size by Type (2017-2022)
4.2 Global Nasal Decolonization Drug Forecasted Market Size by Type (2023-2028)
5 Nasal Decolonization Drug Breakdown Data by Channel
5.1 Global Nasal Decolonization Drug Historic Market Size by Channel (2017-2022)
5.2 Global Nasal Decolonization Drug Forecasted Market Size by Channel (2023-2028)
6 North America
6.1 North America Nasal Decolonization Drug Market Size (2017-2028)
6.2 North America Nasal Decolonization Drug Market Size by Type
6.2.1 North America Nasal Decolonization Drug Market Size by Type (2017-2022)
6.2.2 North America Nasal Decolonization Drug Market Size by Type (2023-2028)
6.2.3 North America Nasal Decolonization Drug Market Share by Type (2017-2028)
6.3 North America Nasal Decolonization Drug Market Size by Channel
6.3.1 North America Nasal Decolonization Drug Market Size by Channel (2017-2022)
6.3.2 North America Nasal Decolonization Drug Market Size by Channel (2023-2028)
6.3.3 North America Nasal Decolonization Drug Market Share by Channel (2017-2028)
6.4 North America Nasal Decolonization Drug Market Size by Country
6.4.1 North America Nasal Decolonization Drug Market Size by Country (2017-2022)
6.4.2 North America Nasal Decolonization Drug Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nasal Decolonization Drug Market Size (2017-2028)
7.2 Europe Nasal Decolonization Drug Market Size by Type
7.2.1 Europe Nasal Decolonization Drug Market Size by Type (2017-2022)
7.2.2 Europe Nasal Decolonization Drug Market Size by Type (2023-2028)
7.2.3 Europe Nasal Decolonization Drug Market Share by Type (2017-2028)
7.3 Europe Nasal Decolonization Drug Market Size by Channel
7.3.1 Europe Nasal Decolonization Drug Market Size by Channel (2017-2022)
7.3.2 Europe Nasal Decolonization Drug Market Size by Channel (2023-2028)
7.3.3 Europe Nasal Decolonization Drug Market Share by Channel (2017-2028)
7.4 Europe Nasal Decolonization Drug Market Size by Country
7.4.1 Europe Nasal Decolonization Drug Market Size by Country (2017-2022)
7.4.2 Europe Nasal Decolonization Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nasal Decolonization Drug Market Size (2017-2028)
8.2 Asia-Pacific Nasal Decolonization Drug Market Size by Type
8.2.1 Asia-Pacific Nasal Decolonization Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nasal Decolonization Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nasal Decolonization Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Nasal Decolonization Drug Market Size by Channel
8.3.1 Asia-Pacific Nasal Decolonization Drug Market Size by Channel (2017-2022)
8.3.2 Asia-Pacific Nasal Decolonization Drug Market Size by Channel (2023-2028)
8.3.3 Asia-Pacific Nasal Decolonization Drug Market Share by Channel (2017-2028)
8.4 Asia-Pacific Nasal Decolonization Drug Market Size by Region
8.4.1 Asia-Pacific Nasal Decolonization Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nasal Decolonization Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nasal Decolonization Drug Market Size (2017-2028)
9.2 Latin America Nasal Decolonization Drug Market Size by Type
9.2.1 Latin America Nasal Decolonization Drug Market Size by Type (2017-2022)
9.2.2 Latin America Nasal Decolonization Drug Market Size by Type (2023-2028)
9.2.3 Latin America Nasal Decolonization Drug Market Share by Type (2017-2028)
9.3 Latin America Nasal Decolonization Drug Market Size by Channel
9.3.1 Latin America Nasal Decolonization Drug Market Size by Channel (2017-2022)
9.3.2 Latin America Nasal Decolonization Drug Market Size by Channel (2023-2028)
9.3.3 Latin America Nasal Decolonization Drug Market Share by Channel (2017-2028)
9.4 Latin America Nasal Decolonization Drug Market Size by Country
9.4.1 Latin America Nasal Decolonization Drug Market Size by Country (2017-2022)
9.4.2 Latin America Nasal Decolonization Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nasal Decolonization Drug Market Size (2017-2028)
10.2 Middle East & Africa Nasal Decolonization Drug Market Size by Type
10.2.1 Middle East & Africa Nasal Decolonization Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nasal Decolonization Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nasal Decolonization Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Nasal Decolonization Drug Market Size by Channel
10.3.1 Middle East & Africa Nasal Decolonization Drug Market Size by Channel (2017-2022)
10.3.2 Middle East & Africa Nasal Decolonization Drug Market Size by Channel (2023-2028)
10.3.3 Middle East & Africa Nasal Decolonization Drug Market Share by Channel (2017-2028)
10.4 Middle East & Africa Nasal Decolonization Drug Market Size by Country
10.4.1 Middle East & Africa Nasal Decolonization Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nasal Decolonization Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Global Life Technologies
11.1.1 Global Life Technologies Company Details
11.1.2 Global Life Technologies Business Overview
11.1.3 Global Life Technologies Nasal Decolonization Drug Introduction
11.1.4 Global Life Technologies Revenue in Nasal Decolonization Drug Business (2017-2022)
11.1.5 Global Life Technologies Recent Developments
11.2 PDI Healthcare
11.2.1 PDI Healthcare Company Details
11.2.2 PDI Healthcare Business Overview
11.2.3 PDI Healthcare Nasal Decolonization Drug Introduction
11.2.4 PDI Healthcare Revenue in Nasal Decolonization Drug Business (2017-2022)
11.2.5 PDI Healthcare Recent Developments
11.3 3M
11.3.1 3M Company Details
11.3.2 3M Business Overview
11.3.3 3M Nasal Decolonization Drug Introduction
11.3.4 3M Revenue in Nasal Decolonization Drug Business (2017-2022)
11.3.5 3M Recent Developments
11.4 Clorox Healthcare
11.4.1 Clorox Healthcare Company Details
11.4.2 Clorox Healthcare Business Overview
11.4.3 Clorox Healthcare Nasal Decolonization Drug Introduction
11.4.4 Clorox Healthcare Revenue in Nasal Decolonization Drug Business (2017-2022)
11.4.5 Clorox Healthcare Recent Developments
11.5 Medline
11.5.1 Medline Company Details
11.5.2 Medline Business Overview
11.5.3 Medline Nasal Decolonization Drug Introduction
11.5.4 Medline Revenue in Nasal Decolonization Drug Business (2017-2022)
11.5.5 Medline Recent Developments
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Nasal Decolonization Drug Introduction
11.6.4 GSK Revenue in Nasal Decolonization Drug Business (2017-2022)
11.6.5 GSK Recent Developments
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Nasal Decolonization Drug Introduction
11.7.4 Teva Revenue in Nasal Decolonization Drug Business (2017-2022)
11.7.5 Teva Recent Developments
11.8 Glenmark Pharms
11.8.1 Glenmark Pharms Company Details
11.8.2 Glenmark Pharms Business Overview
11.8.3 Glenmark Pharms Nasal Decolonization Drug Introduction
11.8.4 Glenmark Pharms Revenue in Nasal Decolonization Drug Business (2017-2022)
11.8.5 Glenmark Pharms Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer